C-reactive protein and n–3 fatty acids in patients with a previous myocardial infarction

Authors:

Abstract
Dietary intake of the marine long-chain n–3 polyunsaturated fatty acids (PUFA) may reduce mortality after a myocardial infarction (MI). This may partly be attributed to their anti-inflammatory properties. To investigate the effect of n–3 PUFA on C-reactive protein (CRP) in patients with a previous MI. In a double-blind design, forty-one patients (mean age 63 ± 7 years) were randomized to receive daily supplements with 5.2 g of n–3 PUFA or olive oil (control). Serum CRP was measured with a highly sensitive assay (hs-CRP) before and after 12 weeks supplements. Compliance was monitored by measuring the incorporation of n–3 PUFA into platelets. The content of n–3 PUFA in platelets increased significantly in the n–3 PUFA supplemented group, whereas no changes were seen in controls. There was a minor increase in hs-CRP in the n–3 PUFA group (2.46 vs. 2.70 mg/l) and a small decrease in hs-CRP in the control group (2.52 vs. 1.67 mg/l). The changes, however, were not statistically significant (P = 0.30 and 0.43, respectively). Supplementation with 5.2 g of n–3 PUFA for 12 weeks had no hs-CRP lowering effect in patients with a previous MI.

This publication has 15 references indexed in Scilit: